Heterochronicity of white matter development and aging explains regional patient control differences in schizophrenia
Altered brain connectivity is implicated in the development and clinical burden of schizophrenia. Relative to matched controls, schizophrenia patients show (1) a global and regional reduction in the integrity of the brain's white matter (WM), assessed using diffusion tensor imaging (DTI) fractional anisotropy (FA), and (2) accelerated age‐related decline in FA values. In the largest mega‐analysis to date, we tested if differences in the trajectories of WM tract development influenced patient–control differences in FA. We also assessed if specific tracts showed exacerbated decline with aging.
Three cohorts of schizophrenia patients (total n = 177) and controls (total n = 249; age = 18‐61 years) were ascertained with three 3T Siemens MRI scanners. Whole‐brain and regional FA values were extracted using ENIGMA‐DTI protocols. Statistics were evaluated using mega‐ and meta‐analyses to detect effects of diagnosis and age‐by‐diagnosis interactions.
In mega‐analysis of whole‐brain averaged FA, schizophrenia patients had lower FA (P = 10−11) and faster age‐related decline in FA (P = 0.02) compared with controls. Tract‐specific heterochronicity measures, that is, abnormal rates of adolescent maturation and aging explained approximately 50% of the regional variance effects of diagnosis and age‐by‐diagnosis interaction in patients. Interactive, three‐dimensional visualization of the results is available at http://www.enigma-viewer.org.
WM tracts that mature later in life appeared more sensitive to the pathophysiology of schizophrenia and were more susceptible to faster age‐related decline in FA values.
Kochunov, P., Ganjgahi, H., Winkler, A., Kelly, S., Shukla, D. K., Du, X., Jahanshad, N., Rowland, L., Sampath, H., Patel, B., O'Donnell, P., Xie, Z., Paciga, S. A., Schubert, C. R., Chen, J., Zhang, G., Thompson, P. M., Nichols, T. E., & Hong, L. E. (2016). Heterochronicity of white matter development and aging explains regional patient control differences in schizophrenia. Human brain mapping, 37(12), 4673–4688. https://doi.org/10.1002/hbm.23336
Human brain mapping
Office of Human Genetics